Foghorn Therapeutics Inc.
FHTX
$4.36
$0.369.00%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 17.12% | 21.95% | 24.71% | 19.09% | -33.30% |
| Total Depreciation and Amortization | 16.23% | 7.59% | -0.96% | -10.68% | -15.16% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 17.38% | -39.71% | -18.73% | -40.72% | -45.08% |
| Change in Net Operating Assets | -32.52% | 20.08% | -0.34% | 1.44% | 71.70% |
| Cash from Operations | 10.21% | 17.77% | 18.32% | 10.97% | 22.80% |
| Capital Expenditure | 100.00% | -29.41% | 72.28% | -1,194.59% | -276.83% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 158.31% | 288.53% | 8.21% | -39.16% | -258.43% |
| Cash from Investing | 158.02% | 288.23% | 8.51% | -40.37% | -259.57% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -96.60% | -99.75% | -88.09% | -97.85% | 3.89% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -95.34% | -99.75% | -88.09% | -97.85% | -24.22% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 120.63% | -78.07% | 614.50% | -122.17% | -744.84% |